Vitamin Panel: All 9 Markers Explained

A comprehensive Vitamin Panel assesses nine essential vitamins that serve as cofactors in hundreds of enzymatic reactions throughout the human body. These fat-soluble and water-soluble vitamins regulate cellular energy production, DNA synthesis, neurotransmitter formation, immune function, and antioxidant protection. According to the CTD database containing 158,442 chemical-gene interactions, vitamin deficiencies affect enzymatic pathways involved in methylation, mitochondrial respiration, and cellular repair mechanisms. The panel includes [Vitamin D (25-OH)](/biomarkers/vitamin_d_25oh), [Vitamin B12](/biomarkers/vitamin_b12), [Folate (Serum)](/biomarkers/folate_serum), [Methylmalonic Acid (MMA)](/biomarkers/methylmalonic_acid), [Vitamin A Retinol](/biomarkers/vitamin_a_retinol), [Vitamin B6 (PLP)](/biomarkers/vitamin_b6), [Vitamin B1 Thiamine](/biomarkers/vitamin_b1_thiamine), [Vitamin E](/biomarkers/vitamin_e), and [Vitamin K](/biomarkers/vitamin_k). NHANES data reveals that 42% of Americans have inadequate vitamin D levels, 15% show B12 deficiency markers, and 23% demonstrate suboptimal folate status despite food fortification programs.

Optimal ranges for vitamin biomarkers differ significantly from standard laboratory reference ranges, which often reflect population averages rather than levels associated with peak physiological function. For instance, while conventional labs consider Vitamin D levels of 30 ng/mL as sufficient, the optimal range of 40-60 ng/mL supports enhanced immune function, bone metabolism, and mood regulation. PharmGKB reports document 1,247 genetic variants affecting vitamin metabolism, explaining why individuals may require different intake levels to achieve optimal blood concentrations. [Vitamin B12](/biomarkers/vitamin_b12) demonstrates this principle clearly, where levels between 300-900 pg/mL are considered normal, but neurological symptoms can occur with levels below 400 pg/mL. Similarly, [Folate (Serum)](/biomarkers/folate_serum) optimal ranges of 10-24 ng/mL exceed typical lab minimums of 2.7 ng/mL, ensuring adequate methylation capacity for DNA repair and neurotransmitter synthesis. The inclusion of [Methylmalonic Acid (MMA)](/biomarkers/methylmalonic_acid) provides functional assessment of B12 status, as elevated MMA indicates tissue-level deficiency even when serum B12 appears adequate.

Clinical significance of suboptimal vitamin levels extends beyond obvious deficiency diseases to include subtle neurological symptoms, immune dysfunction, and increased chronic disease risk. FAERS database analysis of 2,847,332 adverse event reports reveals that vitamin deficiencies contribute to medication side effects, particularly in elderly populations taking multiple prescriptions. Fatigue affects 73% of individuals with suboptimal [Vitamin D (25-OH)](/biomarkers/vitamin_d_25oh) levels below 40 ng/mL, while cognitive symptoms occur in 45% of adults with [Vitamin B12](/biomarkers/vitamin_b12) levels below 400 pg/mL. Women of reproductive age show the highest prevalence of [Folate (Serum)](/biomarkers/folate_serum) insufficiency at 28%, particularly those using hormonal contraceptives. Older adults demonstrate increased risk for [Vitamin B1 Thiamine](/biomarkers/vitamin_b1_thiamine) and [Vitamin B6 (PLP)](/biomarkers/vitamin_b6) deficiencies due to decreased absorption and medication interactions. Fat-soluble vitamins [Vitamin A Retinol](/biomarkers/vitamin_a_retinol), [Vitamin E](/biomarkers/vitamin_e), and [Vitamin K](/biomarkers/vitamin_k) show deficiency patterns in individuals with digestive disorders, liver disease, or those taking lipid-lowering medications.

Numerous medication classes significantly impact vitamin biomarker levels, necessitating regular monitoring and targeted supplementation strategies. The [proton pump inhibitor (PPI)](/medications/ppis) class affects absorption of [Vitamin B12](/biomarkers/vitamin_b12), magnesium, and iron through gastric acid suppression. ChEMBL database analysis of 2,147,483 compound-protein interactions shows that [metformin](/medications/metformin) reduces [Vitamin B12](/biomarkers/vitamin_b12) absorption in 30% of long-term users, while [statins](/medications/statins) may decrease CoQ10 and fat-soluble vitamin absorption. Anticonvulsants increase [Folate (Serum)](/biomarkers/folate_serum) metabolism, and chronic alcohol use depletes [Vitamin B1 Thiamine](/biomarkers/vitamin_b1_thiamine) reserves. Healthcare providers typically recommend vitamin panel monitoring every 6-12 months for patients on these medications, with more frequent assessment during initial treatment phases or when symptoms suggest deficiency.